Conference Compendium

13th Annual Product Recalls Summit

On September 25-27, 2017 in Arlington, VA, delegates gained insight from FDA members and peers on how to improve recall strategies from start to finish. 

"Pharmaceutical recalls increased 28% in Q4 to 83, the highest level since Q3 2014. Recalled united jumped 192% to more than 25.1 million - The highest since Q2 2015 and the third highest since Q1 2012."

-Stericycle Recall Index Q4, 2016

Sessions included in this compendia are:

FDA Regulatory Requirements, Expectations and Trends by Israel Santiago of CDER/Office of Compliance, FDA

Mobilize and Deploy a Field-Based Team During a Recall by Hillary Medina of Novasyte

Senior-Level Think Tank - Assessment Leading into a Recall by Pearley Bhambri of Hill-Rom

Recall Fundamentals and How to Improve Recall Strategies from Start to Finish by Sonali Gunawardhana of Wiley Rein LLP

Ensure Timely and Effective Recall Communication to Minimize the Iimpacts on Brand and Reputation by Maureen Bernier of DAPO, Recall Branch

Implement Successful Execution Strategies for Voluntary Recalls by Lavinia Marinescu-Pederson of Novo Nordisk


This content is only available to IVT members.
Get help maintaining your knowledge . Read More!

If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.

Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.